Effectiveness of Asthma Education Program Based on the Roy Adaptation Model
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Asthma education program.
- Who it may be relevant to
- Registry conditions: Asthma Patients. Basic parameters: 18 years — 64 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effect of Education Given to Asthmatic Individuals According to Roy Adaptation Model on Psychosocial Adjustment and Quality of Life
Overview
The aim of the study; to determine the effect of the education program given to individuals diagnosed with asthma based on Roy's adjustment model on their psychosocial adjustment to the disease and their quality of life.
Detailed description
In addition to the expected physiological effects of asthma on individuals, the course of the disease and the course of the individual's life will change as the duration of living with the disease increases. In order to improve the attitude towards the disease positively in asthmatic individuals, to ensure asthma control and to improve the quality of life by managing the process well, patients' behaviors against the disease should be improved. Regular repetition of trainings created within the framework of a specific plan to improve adaptation behaviors is one of the recommended steps to empower individuals with chronic diseases during the disease process. In this randomized controlled trial, individuals aged 18-64 years with a diagnosis of asthma, an asthma control test (ACT) score of 24-20 (partial control) or ≤19 (uncontrolled) and no secondary chronic disease other than asthma were included.
Interventions
- Behavioral Asthma education program
An educational program based on the Roy Adaptation Model in addition to standard asthma treatment.
Primary outcome measures
- "Evaluation of psychosocial adjustment of asthmatic individuals after education with the Psychosocial Adjustment To Illness-Self-Report Scale (PAIS-SR)". [Time frame: "From enrollment to the end of treatment at 12 weeks"]
Secondary outcome measures (1)
- "Evaluation of the quality of life of asthmatic individuals after education with the Asthma Quality of Life Questionnaire (AQLQ)". [Time frame: "From enrollment to the end of treatment at 12 weeks"]
Eligibility criteria
Inclusion criteria
- Being in the age range of 18-64
- Diagnosed with asthma for at least 6 months
- To live in the city center
- Asthma control test (ACT) score 24-20 (partial control) or ≤19 (uncontrolled)
- Patients who voluntarily agreed to participate in the study
Exclusion criteria
- Has a secondary chronic disease other than asthma
- Diagnosed with neuropsychiatric illness
- Individuals with inability to understand or speak Turkish and sensory problems that prevent communication
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Supportive care
Study locations
Turkey (Türkiye) · 1 center
- Nigde Omer Halisdemir University — Niğde
Publications
- Alpaydin AO, Bora M, Yorgancioglu A, Coskun AS, Celik P. Asthma control test and asthma quality of life questionnaire association in adults. Iran J Allergy Asthma Immunol. 2012 Dec;11(4):301-7. PMID 23264406
- Ozgen Alpaydin A, Yorgancioglu A, Yilmaz O, Bora M, Goktalay T, Celik P, Yuksel H. Validity and reliability of "Asthma Quality of Life Questionnaire" in a sample of Turkish adult asthmatic patients. Tuberk Toraks. 2011;59(4):321-7. PMID 22233301
Identifiers
NCT: NCT06766136 · dnd1